Leading healthcare company Novo Nordisk, which makes all three weight-loss drugs, said it "remains committed to ensuring patient safety" but defended the use of semaglutide and liraglutide
However, as of mid-2025, retatrutide has not received regulatory approval in the UK or elsewhere
Stimulants potentially included in Thrive GLP-1 capsules or activation strips may cause jitteriness, anxiety, insomnia, increased heart rate, or elevated blood pressure
Treatment typically requires intramuscular hydroxocobalamin injections (1 mg three times weekly initially, then every 23 months lifelong) when malabsorption or neurological symptoms are present
Activated charcoal's porous nature may help bind and flush out these toxins, preventing them from entering your bloodstream and causing havoc